The aftermath of SARS-CoV-2 in NICU: saving or checking accounts? Projected cost-effectiveness analysis

被引:1
|
作者
Galderisi, Alfonso [1 ]
Lolli, Elisabetta [1 ]
Cavicchiolo, Maria Elena [1 ]
Bonadies, Luca [1 ]
Trevisanuto, Daniele [1 ]
Baraldi, Eugenio [1 ]
机构
[1] Univ Hosp Padova, Dept Womens & Childrens Hlth, Via N Giustiniani 3, I-35128 Padua, Italy
关键词
Preterm infant; Neonatal intensive care unit; SARS-CoV-2; COVID-19; Cost-effectiveness; Screening;
D O I
10.1007/s00431-020-03884-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In the aftermath of the SARS-CoV-2 pandemic, we revised the cost-effectiveness of the exploited interventions in neonatal intensive care unit, to redefine future strategies for hospital management. Costs were revised with respect to the lockdown R0 or under different R0 scenarios to estimate the cost-effectiveness of the screening program adopted. Weekly nasopharyngeal swabs for parents, neonates, and personnel were the major cost during the pandemic, although they effectively reduced the number of cases in our unit. Conclusion: Parents and healthcare personnel testing appears to be an effective strategy due to the high number of contact they have within the hospital environment and outside, able to minimize the cases within our unit. What is Known: center dot Costs of universal COVID-19 tests for parents, neonates, and NICU personnel have not been evaluated during the COVID-19 pandemic in neonatal intensive care unit in Europe. What is New: center dot Weekly nasopharyngeal swabs for parents, neonates, and personnel were the major cost during the COVID-19 pandemic in NICU. center dot Parents and healthcare personnel testing was effective to reduce costs related to COVID-19 due to the high number of contact they have within the hospital environment and outside.
引用
收藏
页码:1631 / 1635
页数:5
相关论文
共 50 条
  • [1] The aftermath of SARS-CoV-2 in NICU: saving or checking accounts? Projected cost-effectiveness analysis
    Alfonso Galderisi
    Elisabetta Lolli
    Maria Elena Cavicchiolo
    Luca Bonadies
    Daniele Trevisanuto
    Eugenio Baraldi
    European Journal of Pediatrics, 2021, 180 : 1631 - 1635
  • [2] Cost-effectiveness analysis high flow oxygen therapy in the treatment of SARS-CoV-2 pneumonia
    Gonzalez-Castro, A.
    Fito, E. Cuenca
    Fernandez, A.
    Penasco, Y.
    Modesto i Alport, V.
    Villanueva, A. Medina
    Fajardo, A.
    Escude-Acha, P.
    JOURNAL OF HEALTHCARE QUALITY RESEARCH, 2023, 38 (03) : 152 - 157
  • [3] Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis
    Shlomai, Amir
    Leshno, Ari
    Sklan, Ella H.
    Leshno, Moshe
    VALUE IN HEALTH, 2021, 24 (05) : 607 - 614
  • [4] Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea
    Jo, Youngji
    Kim, Sun Bean
    Radnaabaatar, Munkhzul
    Huh, Kyungmin
    Yoo, Jin-Hong
    Peck, Kyong Ran
    Park, Hojun
    Jung, Jaehun
    EPIDEMIOLOGY AND HEALTH, 2022, 44
  • [5] Impact and cost-effectiveness of SARS-CoV-2 self-testing strategies in schools: a multicountry modelling analysis
    Chevalier, Joshua M.
    Han, Alvin X.
    Hansen, Megan A.
    Klock, Ethan
    Pandithakoralage, Hiromi
    Ockhuisen, Tom
    Girdwood, Sarah J.
    Lekodeba, Nkgomeleng A.
    de Nooy, Alexandra
    Khan, Shaukat
    Johnson, Cheryl C.
    Sacks, Jilian A.
    Jenkins, Helen E.
    Russell, Colin A.
    Nichols, Brooke E.
    BMJ OPEN, 2024, 14 (02):
  • [6] Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany
    Nguyen, Hoa Thi
    Denkinger, Claudia M. M.
    Brenner, Stephan
    Koeppel, Lisa
    Brugnara, Lucia
    Burk, Robin
    Knop, Michael
    Baernighausen, Till
    Deckert, Andreas
    De Allegri, Manuela
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (09) : 1545 - 1559
  • [7] Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany
    Hoa Thi Nguyen
    Claudia M. Denkinger
    Stephan Brenner
    Lisa Koeppel
    Lucia Brugnara
    Robin Burk
    Michael Knop
    Till Bärnighausen
    Andreas Deckert
    Manuela De Allegri
    The European Journal of Health Economics, 2023, 24 : 1545 - 1559
  • [8] Cost-Effectiveness Analysis of COVID-19 Inactivated Vaccines in Reducing the Economic Burden of Ischaemic Stroke after SARS-CoV-2 Infection
    Du, Min
    Qin, Chenyuan
    Liu, Min
    Liu, Jue
    VACCINES, 2023, 11 (05)
  • [9] Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: a modelling and economic analysis study
    Mark Drakesmith
    Brendan Collins
    Angela Jones
    Kelechi Nnoaham
    Daniel Rhys Thomas
    BMC Health Services Research, 22
  • [10] Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: a modelling and economic analysis study
    Drakesmith, Mark
    Collins, Brendan
    Jones, Angela
    Nnoaham, Kelechi
    Thomas, Daniel Rhys
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)